Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000930413-25-001704
Filing Date
2025-05-12
Accepted
2025-05-12 07:40:50
Documents
52

Document Format Files

Seq Description Document Type Size
1 c112651_defa14a.htm DEFA14A 130848
2 GRAPHIC x1_c112651x1x1.jpg GRAPHIC 1032635
3 GRAPHIC x1_c112651x2x1.jpg GRAPHIC 2208634
4 GRAPHIC x1_c112651x3x1.jpg GRAPHIC 1878423
5 GRAPHIC x1_c112651x4x1.jpg GRAPHIC 816932
6 GRAPHIC x1_c112651x5x1.jpg GRAPHIC 1577583
7 GRAPHIC x1_c112651x6x1.jpg GRAPHIC 1267918
8 GRAPHIC x1_c112651x7x1.jpg GRAPHIC 1456838
9 GRAPHIC x1_c112651x8x1.jpg GRAPHIC 1592271
10 GRAPHIC x1_c112651x9x1.jpg GRAPHIC 1000919
11 GRAPHIC x1_c112651x10x1.jpg GRAPHIC 1201607
12 GRAPHIC x1_c112651x11x1.jpg GRAPHIC 1505058
13 GRAPHIC x1_c112651x12x1.jpg GRAPHIC 1563008
14 GRAPHIC x1_c112651x13x1.jpg GRAPHIC 1135578
15 GRAPHIC x1_c112651x14x1.jpg GRAPHIC 1193090
16 GRAPHIC x1_c112651x15x1.jpg GRAPHIC 1162388
17 GRAPHIC x1_c112651x16x1.jpg GRAPHIC 1798573
18 GRAPHIC x1_c112651x17x1.jpg GRAPHIC 981978
19 GRAPHIC x1_c112651x18x1.jpg GRAPHIC 1098447
20 GRAPHIC x1_c112651x19x1.jpg GRAPHIC 741576
21 GRAPHIC x1_c112651x20x1.jpg GRAPHIC 1455966
22 GRAPHIC x1_c112651x21x1.jpg GRAPHIC 945898
23 GRAPHIC x1_c112651x22x1.jpg GRAPHIC 1767620
24 GRAPHIC x1_c112651x23x1.jpg GRAPHIC 1053013
25 GRAPHIC x1_c112651x24x1.jpg GRAPHIC 1337225
26 GRAPHIC x1_c112651x25x1.jpg GRAPHIC 845426
27 GRAPHIC x1_c112651x26x1.jpg GRAPHIC 1107059
28 GRAPHIC x1_c112651x27x1.jpg GRAPHIC 1086664
29 GRAPHIC x1_c112651x28x1.jpg GRAPHIC 1240917
30 GRAPHIC x1_c112651x29x1.jpg GRAPHIC 1592251
31 GRAPHIC x1_c112651x30x1.jpg GRAPHIC 1284135
32 GRAPHIC x1_c112651x31x1.jpg GRAPHIC 1504536
33 GRAPHIC x1_c112651x32x1.jpg GRAPHIC 1415161
34 GRAPHIC x1_c112651x33x1.jpg GRAPHIC 1566392
35 GRAPHIC x1_c112651x34x1.jpg GRAPHIC 1467424
36 GRAPHIC x1_c112651x35x1.jpg GRAPHIC 1497473
37 GRAPHIC x1_c112651x36x1.jpg GRAPHIC 1208014
38 GRAPHIC x1_c112651x37x1.jpg GRAPHIC 1382582
39 GRAPHIC x1_c112651x38x1.jpg GRAPHIC 1397445
40 GRAPHIC x1_c112651x39x1.jpg GRAPHIC 1597142
41 GRAPHIC x1_c112651x40x1.jpg GRAPHIC 1350426
42 GRAPHIC x1_c112651x41x1.jpg GRAPHIC 1602081
43 GRAPHIC x1_c112651x42x1.jpg GRAPHIC 1440273
44 GRAPHIC x1_c112651x43x1.jpg GRAPHIC 1229925
45 GRAPHIC x1_c112651x44x1.jpg GRAPHIC 639949
46 GRAPHIC x1_c112651x45x1.jpg GRAPHIC 1878773
47 GRAPHIC x1_c112651x46x1.jpg GRAPHIC 1046684
48 GRAPHIC x1_c112651x47x1.jpg GRAPHIC 652222
49 GRAPHIC x1_c112651x48x1.jpg GRAPHIC 1408634
50 GRAPHIC x1_c112651x49x1.jpg GRAPHIC 1412458
51 GRAPHIC x1_c112651x50x1.jpg GRAPHIC 1548127
52 GRAPHIC x1_c112651x51x1.jpg GRAPHIC 1446788
  Complete submission text file 0000930413-25-001704.txt   93169668
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 25932607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)